The Current Ratio as of September 2024 (TTM) for Rhythm Pharmaceuticals, Inc. (RYTM) is 6.53

According to Rhythm Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.53. This represents a change of 13.41% compared to the average of 5.76 of the last 4 quarters.

Rhythm Pharmaceuticals, Inc. (RYTM) Historical Current Ratio (quarterly & annually)

How has RYTM Current Ratio performed in the past?

The mean historical Current Ratio of Rhythm Pharmaceuticals, Inc. over the last ten years is 9.50. The current 6.53 Current Ratio has changed 6.78% with respect to the historical average. Over the past ten years (40 quarters), RYTM's Current Ratio was at its highest in in the June 2018 quarter at 40.12. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Rhythm Pharmaceuticals, Inc. (RYTM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Rhythm Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rhythm Pharmaceuticals, Inc. (RYTM) Average Current Ratio

How has RYTM Current Ratio performed in the past?

The current Current Ratio of Rhythm Pharmaceuticals, Inc. (RYTM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rhythm Pharmaceuticals, Inc. (RYTM) Current Ratio vs. Peers

How is RYTM’s Current Ratio compared to its peers?

Rhythm Pharmaceuticals, Inc.’s Current Ratio is less than Revolution Medicines, Inc. (15.42), less than Akero Therapeutics, Inc. (24.89), less than Avidity Biosciences, Inc. (15.78), less than Protagonist Therapeutics, Inc. (13.73), less than Stoke Therapeutics, Inc. (6.67), less than uniQure N.V. (7.36), less than Rocket Pharmaceuticals, Inc. (7.79), less than Solid Biosciences Inc. (13.45), greater than MeiraGTx Holdings plc (2.36), less than Nuvalent, Inc. (17.44), less than Ventyx Biosciences, Inc. (14.19), greater than Arcellx, Inc. (6.01), less than Cullinan Oncology, Inc. (28.87), greater than Kiniksa Pharmaceuticals, Ltd. (3.57), less than Pliant Therapeutics, Inc. (14.47), less than Syndax Pharmaceuticals, Inc. (10.50), less than Viridian Therapeutics, Inc. (15.82), less than Inozyme Pharma, Inc. (9.84), less than Relay Therapeutics, Inc. (15.64), less than Black Diamond Therapeutics, Inc. (6.87), greater than Arvinas, Inc. (3.62),

Build a custom stock screener for Rhythm Pharmaceuticals, Inc. (RYTM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhythm Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rhythm Pharmaceuticals, Inc. (RYTM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rhythm Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.